These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15937641)

  • 61. Craniopharyngioma: Survivin expression and ultrastructure.
    Zhu J; You C
    Oncol Lett; 2015 Jan; 9(1):75-80. PubMed ID: 25435936
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Caspase-3 and survivin expression in primary atypical and malignant meningiomas.
    Vranic A
    ISRN Neurosci; 2013; 2013():626290. PubMed ID: 25006573
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Survivin delta Ex3 overexpression in thyroid malignancies.
    Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Biczysko M; Jankowska A; Kubiczak M; Czarnywojtek A; Wrotkowska E; Ruchała M
    PLoS One; 2014; 9(6):e100534. PubMed ID: 24945990
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression and clinical significance of Wnt players and survivin in pituitary tumours.
    Formosa R; Gruppetta M; Falzon S; Santillo G; DeGaetano J; Xuereb-Anastasi A; Vassallo J
    Endocr Pathol; 2012 Jun; 23(2):123-31. PubMed ID: 22327960
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.
    Ammoun S; Cunliffe CH; Allen JC; Chiriboga L; Giancotti FG; Zagzag D; Hanemann CO; Karajannis MA
    Neuro Oncol; 2010 Aug; 12(8):834-43. PubMed ID: 20511180
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light.
    Al-Mohanna MA; Al-Khalaf HH; Al-Yousef N; Aboussekhra A
    Nucleic Acids Res; 2007; 35(1):223-33. PubMed ID: 17158160
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Survivin expression in ganglioglioma.
    Rousseau A; Kujas M; Bergemer-Fouquet AM; van Effenterre R; Hauw JJ
    J Neurooncol; 2006 Apr; 77(2):153-9. PubMed ID: 16292482
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of survivin and p16(INK4a)/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells.
    Al-Khalaf HH; Lach B; Allam A; Hassounah M; Alkhani A; Elkum N; Alrokayan SA; Aboussekhra A
    Brain Res; 2008 Jan; 1188():25-34. PubMed ID: 18048012
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
    Sasaki T; Lopes MB; Hankins GR; Helm GA
    Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras.
    Sommer KW; Schamberger CJ; Schmidt GE; Sasgary S; Cerni C
    Oncogene; 2003 Jul; 22(27):4266-80. PubMed ID: 12833149
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice.
    Thomas J; Liu T; Cotter MA; Florell SR; Robinette K; Hanks AN; Grossman D
    Cancer Res; 2007 Jun; 67(11):5172-8. PubMed ID: 17545596
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Benign tumors from the human nervous system express high levels of survivin and are resistant to spontaneous and radiation-induced apoptosis.
    Hassounah M; Lach B; Allam A; Al-Khalaf H; Siddiqui Y; Pangue-Cruz N; Al-Omeir A; Al-Ahdal MN; Aboussekhra A
    J Neurooncol; 2005 May; 72(3):203-8. PubMed ID: 15937641
    [TBL] [Abstract][Full Text] [Related]  

  • 73. To die or not to die: how does p53 decide?
    Slee EA; O'Connor DJ; Lu X
    Oncogene; 2004 Apr; 23(16):2809-18. PubMed ID: 15077144
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.
    Kayaselçuk F; Zorludemir S; Bal N; Erdogan B; Erdogan S; Erman T
    J Neurooncol; 2004; 67(1-2):209-14. PubMed ID: 15072469
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Survivin, versatile modulation of cell division and apoptosis in cancer.
    Altieri DC
    Oncogene; 2003 Nov; 22(53):8581-9. PubMed ID: 14634620
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Survivin in brain tumors: an attractive target for immunotherapy.
    Katoh M; Wilmotte R; Belkouch MC; de Tribolet N; Pizzolato G; Dietrich PY
    J Neurooncol; 2003; 64(1-2):71-6. PubMed ID: 12952288
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Validating survivin as a cancer therapeutic target.
    Altieri DC
    Nat Rev Cancer; 2003 Jan; 3(1):46-54. PubMed ID: 12509766
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
    Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
    Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apoptosis: a link between cancer genetics and chemotherapy.
    Johnstone RW; Ruefli AA; Lowe SW
    Cell; 2002 Jan; 108(2):153-64. PubMed ID: 11832206
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.